NW-4-241

N/A

Report date: 2022/11/25 16:45:12
NME

Base Information

Drug NameNW-4-241
Drug Alias NameNW-4-241
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGuangzhou Lupeng Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGuangzhou Lupeng Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A